Chemical formula: C₂₁₅H₃₅₈N₇₂O₆₆S Molecular mass: 5,038.666 g/mol
Somatorelin is normally synthesised in the hypothalamus and stimulates the secretion of growth hormone from the pituitary gland. Somatorelin physiologically increases plasma growth hormone levels.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V04CD05 | Somatorelin | V Various → V04 Diagnostic agents → V04C Other diagnostic agents → V04CD Tests for pituitary function |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| GHRH Lyophilised powder for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Somatorelin is an active ingredient of these brands:
France (FR)
Spain (ES)
United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
